Nan YM - Search Results

1

[A clinical study of targeted immunotherapy combined with hepatic arterial chemoembolization in the treatment of liver injury associated with primary liver cancer].

Liu LD, Dong SM, Li YY, Nan YM. Liu LD, et al. Among authors: nan ym. Zhonghua Gan Zang Bing Za Zhi. 2023 Nov 20;31(11):1156-1162. doi: 10.3760/cma.j.cn501113-20230915-00109. Zhonghua Gan Zang Bing Za Zhi. 2023. PMID: 38238948 Chinese.

2

[The effect of serum TGFb1 of patients with chronic hepatitis B in liver fibrosis formation].

Liu F, Li B, Nan Y. Liu F, et al. Zhonghua Gan Zang Bing Za Zhi. 1999 Dec;7(4):196-8. Zhonghua Gan Zang Bing Za Zhi. 1999. PMID: 10715784 Chinese.

3

[Clinicopathological features of early- and late-stage primary biliary cirrhosis: a comparative study].

Zhao SX, Zhang YG, Zhou GD, Wang RQ, Zhang QS, Li WC, Ren WG, Nan YM, Zhao JM. Zhao SX, et al. Among authors: nan ym. Zhonghua Gan Zang Bing Za Zhi. 2016 Jun;24(6):412-6. doi: 10.3760/cma.j.issn.1007-3418.2016.06.004. Zhonghua Gan Zang Bing Za Zhi. 2016. PMID: 27465943 Chinese.

4

[Clinical features of drug-induced autoimmune hepatitis and drug-induced liver injury: a comparative analysis].

Zhao SX, Zhang YG, Tan PF, Wang RQ, Nan YM. Zhao SX, et al. Among authors: nan ym. Zhonghua Gan Zang Bing Za Zhi. 2016 Apr;24(4):302-6. doi: 10.3760/cma.j.issn.1007-3418.2016.04.012. Zhonghua Gan Zang Bing Za Zhi. 2016. PMID: 27470631 Chinese.

5

[Correlation of FibroTouch and FibroScan with the stage of primary biliary cirrhosis].

Zhang YG, Zhao SX, Zhou GD, Li WC, Ren WG, Du HJ, Wang RQ, Nan YM. Zhang YG, et al. Among authors: nan ym. Zhonghua Gan Zang Bing Za Zhi. 2016 Dec 20;24(12):902-906. doi: 10.3760/cma.j.issn.1007-3418.2016.12.005. Zhonghua Gan Zang Bing Za Zhi. 2016. PMID: 28073410 Chinese.

6

[Current status and perspectives of diagnosis and treatment of complications related to liver cirrhosis].

Nan YM. Nan YM. Zhonghua Gan Zang Bing Za Zhi. 2017 Apr 20;25(4):241-245. doi: 10.3760/cma.j.issn.1007-3418.2017.04.001. Zhonghua Gan Zang Bing Za Zhi. 2017. PMID: 28494539 Chinese.

7

[Mechanism of action of Yiqi Huoxue Recipe in regulating autophagy and reversing liver fibrosis].

Wang BY, Zhao W, Niu XM, Du JH, Fu N, Zhao SX, Wang Y, Wang RQ, Zhang YG, Nan YM. Wang BY, et al. Among authors: nan ym. Zhonghua Gan Zang Bing Za Zhi. 2017 May 20;25(5):365-370. doi: 10.3760/cma.j.issn.1007-3418.2017.05.011. Zhonghua Gan Zang Bing Za Zhi. 2017. PMID: 28763844 Chinese.

8

[An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017].

Nan YM, Fu N, Li WC, Kong LL, Yuan XW, Zhang SY, Liu LD, Lu Y, Cui LY. Nan YM, et al. Zhonghua Gan Zang Bing Za Zhi. 2017 Sep 20;25(9):687-694. doi: 10.3760/cma.j.issn.1007-3418.2017.09.008. Zhonghua Gan Zang Bing Za Zhi. 2017. PMID: 29108191 Chinese.

9

[Qualitative pathological assessment of liver fibrosis regression after antiviral therapy in patients with chronic hepatitis B].

Sun YM, Zhou JL, Wang L, Wu XN, Chen YP, Piao HX, Lu LG, Jiang W, Xu YQ, Feng B, Nan YM, Xie W, Chen GF, Zheng HW, Li H, Ding HG, Liu H, Lyu FD, Shao C, Wang TL, Ou XJ, Wang BQ, Chen SY, You H, Jia JD. Sun YM, et al. Among authors: nan ym. Zhonghua Gan Zang Bing Za Zhi. 2017 Nov 20;25(11):819-826. doi: 10.3760/cma.j.issn.1007-3418.2017.11.005. Zhonghua Gan Zang Bing Za Zhi. 2017. PMID: 29325275 Chinese.

10

[Advances in diagnosis and treatment of liver cirrhosis with integrated traditional Chinese and Western medicine].

Nan YM, Kong LL. Nan YM, et al. Zhonghua Gan Zang Bing Za Zhi. 2018 May 20;26(5):328-331. doi: 10.3760/cma.j.issn.1007-3418.2018.05.003. Zhonghua Gan Zang Bing Za Zhi. 2018. PMID: 29996198 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters